REGENERON PHARMACEUTICALS, INC. (REGN)
Earnings Overview
Next Earnings Date
April 30, 2026
REGENERON PHARMACEUTICALS, INC. (REGN) reported Dec-25 earnings with EPS of $11.44 EPS was down 5% year-over-year. Revenue grew 3% YoY. Next earnings report is expected on April 30, 2026.
Annual
| Year | EPS | YoY | Revenue (Bil) | YoY |
|---|---|---|---|---|
| 2025 | 44.38 | -3% | 14.34 | +1% |
| 2024 | 45.64 | +4% | 14.20 | +8% |
| 2023 | 43.78 | +3% | 13.12 | +8% |
Quarterly
| Quarter | EPS | YoY | Revenue (Bil) | YoY |
|---|---|---|---|---|
| Dec-25 | 11.44 | -5% | 3.88 | +3% |
| Sep-25 | 11.83 | -5% | 3.75 | +1% |
| Jun-25 | 12.89 | +12% | 3.68 | +4% |
| Mar-25 | 8.22 | -14% | 3.03 | -4% |
Get the full REGN analysis
Sign up for earnings surprises, estimates, performance scores, insider trades, institutional ownership, and more.
Free forever with optional upgrade
Earnings Surprises
Beat/miss data for every quarter
Performance Score
Proprietary earnings quality rating
Insider Trading
Recent insider buys and sells
Institutional Ownership
Top holders and quarterly changes
Earnings Calendar
Upcoming earnings dates and estimates
Stock Screener
Filter stocks by earnings metrics
Analyst Estimates
Forward EPS and revenue estimates
Price Targets
Analyst price targets and upgrades/downgrades